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Background: GBL (gamma-butyrolactone) is a 
‘pro-drug’ of GHB, which means that it converts 
to GHB within the body. GBL occurs naturally in 
certain food products, is found in small quantities 
in the human body and is available commercially 
as an industrial solvent and as an ingredient in 
cleaners, paint removers and engine degreasers 1. 
GHB is a drug which is available as sodium 
oxybate (or under the brand name Xyrem) as a 
treatment for narcolepsy in adult patients 3 and 
has been used therapeutically in the treatment of 
alcohol and opiate dependency 1,2. GHB was developed in the early 60s as a human 
anaesthetic2a, but was discontinued due to unwanted side effects. It was used as 
a sleep aid and body building supplement in the 80s and 
later as a recreational psychoactive2b. GHB and GBL are 
sometimes referred to as G, Liquid Ecstasy, Liquid X, Juice 
or Geebs.
Drug class: GBL is not active in its own right; its mechanism 
of action stems from its identity as a pro-drug of GHB. GHB 
is a central nervous system (CNS) depressant, with sedative 
and anaesthetic qualities.  
Legal status: GHB was brought under the Misuse of Drugs Act as a Class C drug in 
2003. As some users then switched to GBL and 1,4-BD as legal alternatives to GHB 8, 
these were also brought under the control of the Misuse of Drugs Act as Class C drugs 
in 2009 9. There are some exceptions to GBL’s legal status that cover its legitimate (i.e. 
non-recreational) use 23.
Appearance and taste: At room temperature GBL is a colourless, slightly oily liquid 
that is clear to semi-opaque. It has a distinctive taste that some users have described 
as being distinctly chemical, like a solvent, nail varnish or paint stripper 4, 5, 19. 
Route of administration: GBL is mainly taken orally. Due both to its unpleasant taste 
and to it being a skin irritant, most users dilute it with juice or other liquid. IV use is 
strongly advised against; one user reported that this lead to “the most horrific pain 
you can think of… the tiny amount of GBL that was on the outside of the needle was 
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Dependence and withdrawal: Regular use of GBL builds tolerance, meaning users 
need to take more to feel the same effects. GBL is physically addictive and stopping it 
without medical supervision can be fatal; sudden withdrawal poses dangerous health 
risks and can require an in-patient detox . 10,19 Clinical presentation of withdrawal may 
include anxiety, confusion, agitation, tremor, cramps, insomnia, aggression, delirium, 
delusions, paranoia with hallucinations, tachycardia (racing heart), low blood pressure 
and occasionally a schizophrenic-like state.2 ,10
Typical effects and side effects:1, 7, 8, 9, 10, 15, 18, 27 These are some of the typical effects 
and side effects experienced by people who use GBL; not everyone will experience all 
effects listed and many can be dose dependent.
Physical Mental
Physical relaxation Heightened sex drive Euphoria Loss of inhibitions
Can enhance effects 
of stimulant drugs
Increased erections Increases dopamine 
levels
Can ease stimulant 
comedowns
Unconsciousness Increased orgasms Enhanced sociability Sleep aid
Nausea and vomiting Hypothermia Anxiety Aggression
Physical addiction Severe respiratory 
depression
Paranoia Confusion
Collapse Death Psychological 
addiction
Coma
Onset and duration of effects: Onset varies between individuals and can depend 
on a number of factors (including when the user last ate), but effects can be felt 
approximately 10-30 minutes after ingestion. 45 minutes to 1 hour later the effects 
begin to level off and decrease ; 26,28 depending on tolerance to the drug its effects 
can be felt for 2-4 hours . 19 After-effects like grogginess and sleepiness can be felt for 
as little as two hours or as long as twelve hours after use, although some users find a 
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Overdose: GBL can be fatal. It is very easy to overdose on it, both because the strength 
can vary from bottle to bottle and because the doses involved are measured in such 
small quantities . 12 These risks are greatly increased by mixing GBL with alcohol or 
other sedative, depressant drugs or drugs such as ketamine. Mixing with alcohol is 
particularly dangerous as this can trigger instant collapse or an overdose reaction. 
2 , 8, 10, 11, 13, 14, 15 GHB and GBL have been found to reduce the efficiency of some HIV 
medication and have also been implicated in sexual assaults or ‘date rapes’ . 8 , 15, 16, 17
Dosage information: GBL has a very steep dose-response curve, meaning that it can 
only take a tiny amount to push the user from having a good time to experiencing 
accidental overdose, unconsciousness, coma or even death . 10 Some rough guidelines 
follow, please note that these will not apply to everyone who takes the drug:
Low Dose Medium Dose Heavy Dose/Overdose
0.3-0.6mls 0.6-1.25mls 1.25-2mls+
Individual responses to the drug appear to vary greatly  depending on a range of 
factors including body weight/size and gender 24 and it is highly recommended that 
users measure carefully and start with a smaller dose, for example 0.3mls to test 
their response to the drug. Once this ‘starting point’ dose has been found (for some 
users this might be between 0.3mls and 0.7mls) users can wait, and then re-dose at 
this same level until a ‘sweet spot’ is found . 22, 25 Reports of re-dosing times vary from 
waiting between 30 minutes to 2 hours , 18, 19, 20 and one user recommends sipping 
slowly over time to maintain the high.18 Some users choose to take a single larger 
amount (around 1.25-2mls) instead of smaller doses; taking a dose such as this could 
however push you into unconsciousness. Although everyone responds differently to 
GBL, having more than 2-2.5mls in your body at one time can put you at risk of 
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GBL harm reduction information: 
If you are experiencing any symptoms of withdrawal from GHB or GBL please seek 
medical advice before stopping.
•	 Avoid mixing with alcohol. Alcohol and GBL is a very dangerous combination; as is 
mixing GBL with any sedatives or depressants, or drugs such as ketamine.
•	 Always measure dosage carefully; never swig from a bottle. As there is very little 
way of working out how pure or how concentrated/diluted your GBL is, extreme 
caution should be used when measuring doses. For precise measuring, try using 
a 1 or 2ml syringe, or if using a pipette or eye dropper ensure that it is marked in 
millilitres.
•	 To be safe, wait for 2 hours before re-dosing.
•	 Do not assume that two different bottles of GBL are of the same strength.
•	 Do not assume that you should take the same amount as your friends, different 
people react very differently to GBL.
•	 Do not drive or operate machinery after taking GBL.
•	 Use a food colouring to differentiate it from other liquids.
•	 Avoid frequent use to prevent dependency developing.
•	 If you feel you are becoming addicted to GHB or GBL, please seek medical attention 
before stopping.
As unconsciousness is common try to make sure a friend is around who is not using 
the drug. If a user becomes unconscious but is still breathing call an ambulance then 
place them in the recovery position to prevent choking (see images below). Check 
that they are still breathing; if they wake up don’t give them anything to eat or drink. 
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The recovery position is for someone who is unconscious but breathing normally. 
If they are not breathing normally CPR is required, with an emphasis on giving 
supplementary oxygen via rescue breaths.
For further information on Overdose & Emergencies see UK and Ireland DrugWatch 
Information Sheet. 
Where to get help: We would advise anyone experiencing issues from GBL, GHB 
or other substances to seek medical support via their GP or the NHS. There are a 
wide range of local drug services throughout the UK, to find out what is available 
in your area please use the links below:
       England: Find Support | Frank   Scotland: Scottish Drug Services 
   Wales: Dan 24/7   Northern Ireland: Public Health Agency   ROI: Drugs.IE
For further advice, medical professionals can use the National Poisons Information 
Service 24-hour telephone service on 0344 892 0111 or its online database, TOXBASE. 
Any health professional encountering an unusual or unexpected adverse reaction to 
the use of GBL (or any other drug) should report the reaction to RIDR. 
Written by Mark Adley in association with UK and Ireland DrugWatch: an informal online 
professional information network established by a group of professionals working in 
the UK and Irish drugs sector. The aim of the group is to raise/establish standards for 
drug information, alerts and warnings. It is currently an unfunded, bottom-up initiative 
that works in the spirit of mutual co-operation. Details of current members can be 
found here.
Start by placing their 
arm as if they are 
waving.
Place the other arm 
across their chest and 
hold their hand against 
their cheek.
Lift up the knee that 
is furthest from you. 
Continue to hold their 
hand in place.
Turn them on their side 
by pulling the knee 
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